Insider Buying: CVS Group (LON:CVSG) Insider Acquires 2,000 Shares of Stock

CVS Group plc (LON:CVSG) insider Richard Gray bought 2,000 shares of CVS Group stock in a transaction dated Monday, January 5th. The stock was purchased at an average price of £1,276.96 per share, with a total value of £2,553,920.

CVS Group Stock Up 1.3%

Shares of CVSG traded up GBX 16.27 during trading hours on Tuesday, reaching GBX 1,292.27. The stock had a trading volume of 1,433,788 shares, compared to its average volume of 866,677. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52. The firm has a 50-day simple moving average of GBX 1,225.01 and a 200 day simple moving average of GBX 1,247.24. CVS Group plc has a 12 month low of GBX 800 and a 12 month high of GBX 1,648. The company has a market capitalization of £918.00 million, a price-to-earnings ratio of 17.56, a P/E/G ratio of 1.77 and a beta of 1.02.

CVS Group (LON:CVSG) last released its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 earnings per share for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. Equities research analysts predict that CVS Group plc will post 93.9393939 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Royal Bank Of Canada raised their price target on shares of CVS Group from GBX 1,500 to GBX 1,900 and gave the company an “outperform” rating in a research report on Tuesday, October 21st. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Tuesday, November 18th. Deutsche Bank Aktiengesellschaft boosted their target price on CVS Group from GBX 1,500 to GBX 1,700 and gave the stock a “buy” rating in a research note on Tuesday, October 21st. Peel Hunt reaffirmed a “buy” rating and set a GBX 1,600 price target on shares of CVS Group in a research report on Tuesday, November 18th. Finally, Jefferies Financial Group lifted their price target on CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a “hold” rating in a report on Wednesday, October 22nd. Four equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of GBX 1,724.

CVS Group Company Profile

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.